How can opioid deaths be reduced? New studies further verify the benefits of pharmacotherapy for opioid dependence in greatly reducing all-cause mortality rates.
Deaths in custody: ‘Every Aboriginal family has a story’ It’s been 30 years since the royal commission first tabled its recommendations and GPs are calling for more action.
Who is seeking pharmacotherapy treatment for opioid dependence? Annual data examines who, where and why on a ‘snapshot day’ in 2020, and how treatment has progressed.
More than 70% of Australian COVID deaths had pre-existing conditions New data released by the ABS provides insight into COVID-19 deaths throughout the country.
Mundipharma fined for misleading advertising of opioids The international affiliate of Purdue Pharma was issued 24 infringement notices by the Therapeutic Goods Administration.
New patient guide aims to reduce opioid harms A lack of information regarding opioid use after hospital discharge can be dangerous for some patients, but a new guide aims to close that gap.
Advocates hail ‘game changing’ PBS listing of buprenorphine Harm-reduction advocates have long called for an end to the surprisingly high cost of opioid substitution therapy.
National flu death toll tops 250 Australia is battling through one of its deadliest flu seasons on record.
Hospital to introduce opioid plan to tackle risk of post-surgery dependence A Perth hospital will move to introduce opioid-weaning plans for post-surgery patients in a bid to address rising rates of opioid dependency.
Flu death toll rises Australia’s horror early flu season has continued, with the confirmed number of influenza-related mortalities now at 79.